International Journal of Oral & Maxillofacial Surgery
Volume 39, Issue 3 , Pages 251-255 , March 2010

Surgical management of bisphosphonate induced osteonecrosis of the jaws

  • R.A. Williamson

      Affiliations

    • Corresponding Author InformationTel.: +61 8 9346 7622/94502911; fax: +61 8 9346 7623.

,Accepted 20 November 2009.

References 

  1. American Dental Association Council on Scientific Affairs. Expert panel recommendations: dental management of patients receiving oral bisphosphonate therapy. J Am Dental Assoc. 2006;137:1144–1150
  2. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006;24(February (6)):945–952
  3. Carter GD, Goss AN. Bisphosphonates and avascular necrosis of the jaws. Aust Dent J. 2003;48:268
  4. Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J. 2005;50((4) Suppl. 2):S4–13
  5. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99–102
  6. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidrounate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol. 1998;16:2038–2044
  7. Kademani D, Kora S, Lacy MQ, Rajkumar SV. Surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc. 2006;81(8):100–1103
  8. Marx RE. Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–1117
  9. Pogrel MA. Bisphosphonates and bone necrosis. J Oral Maxillofac Surg. 2004;62:391–392
  10. Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Prac. 2006;2(January (1)):7–14
  11. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527–534
  12. Vincenzi B, Santini D, Rocci L, Tonini G. Bisphosphonates: new antiangiogenic molecules in cancer treatment?. Ann Oncol. 2003;14:806–807
  13. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg. 2003;61:1104–1107
  14. Watts NB. Bisphosphonate treatment of osteoporosis. Clin Geriatr Med. 2003;19:395–414

PII: S0901-5027(09)01180-1

doi: 10.1016/j.ijom.2009.11.014

International Journal of Oral & Maxillofacial Surgery
Volume 39, Issue 3 , Pages 251-255 , March 2010

Article Tools

* Image Usage & Resolution